CI-624

CI-624 decrease secretion volumes and outputs of hydrogen, sodium and potassium ions and of pepsin. CI-624 can be used in the research of cancer and autoimmune diseases[1].

Product Specifications

CAS Number

[700-07-2]

UNSPSC

12352005

Hazard Statement

H302-H315-H319-H335

Target

Histamine Receptor; Insulin Receptor

Related Pathways

GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling; Protein Tyrosine Kinase/RTK

Field of Research

Cancer; Inflammation/Immunology

Smiles

CNC1=C2C=CC=CC2=NS1

Molecular Formula

C8H8N2S

Molecular Weight

164.23

Precautions

P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

References & Citations

[1]Paul Bass, et al. GASTRIC ANTISECRETORY AND OTHER PHARMACOLOGIC STUDIES OF 3-METHYLAMINO-2,1-BENZISOTHIAZOLE. The Journal of Pharmacology and Experimental Therapeutics. Volume 153, Issue 2p292-300August 1966.